Mark Sutherland

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Emergency Department

Transforming Growth Factor

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Asiye Busra Boz Er, Helen M Sheldrake, Mark Sutherland
Overcoming Vemurafenib Resistance in Metastatic Melanoma: Targeting Integrins to Improve Treatment Efficacy. International journal of molecular sciences 25 (14) (2024)
Asiye Busra Boz Er, Helen M Sheldrake, Mark Sutherland
Overcoming Vemurafenib Resistance in Metastatic Melanoma: Targeting Integrins to Improve Treatment Efficacy. International journal of molecular sciences 25 (14) (2024)
Asiye Busra Boz Er, Helen M Sheldrake, Mark Sutherland
Overcoming Vemurafenib Resistance in Metastatic Melanoma: Targeting Integrins to Improve Treatment Efficacy. International journal of molecular sciences 25 (14) (2024)
Mark Sutherland, Andrew Gordon, Fatemah O F O Alshammari, Adam Throup, Amy Cilia La Corte, Helen Philippou, Steven D Shnyder, Laurence H Patterson, Helen M Sheldrake
Synthesis and Biological Evaluation of Cyclobutane-Based β3 Integrin Antagonists: A Novel Approach to Targeting Integrins for Cancer Therapy. Cancers 15 (16) (2023)